Today: 16 June 2026
Browse Category

NASDAQ:BKYI 27 October 2025 - 28 January 2026

BKYI stock jumps premarket after BIO-key lands Portugal digital identity deal with Visualforma

BKYI stock jumps premarket after BIO-key lands Portugal digital identity deal with Visualforma

BIO-key shares jumped about 36% to $0.74 in premarket trading after announcing a contract to deploy its biometric solutions across over 250 Portuguese public-sector organizations. The company remains below Nasdaq’s $1 minimum bid price and has until May 2026 to regain compliance or face delisting. Financial terms of the Portugal deal were not disclosed. BKYI closed Tuesday at roughly $0.55.
28 January 2026
·
BIO-key (BKYI) spikes on major Middle East defense biometric deployment — stock reacts as company expands EMEA footprint [Nov. 7, 2025]

BIO-key (BKYI) spikes on major Middle East defense biometric deployment — stock reacts as company expands EMEA footprint [Nov. 7, 2025]

BIO‑key International announced a major biometric security deployment with an unnamed Middle East defense-sector client, calling it one of its largest regional wins. Shares of BKYI surged as much as 55% in pre-market trading and hovered around $0.63 by early afternoon. The project uses BIO‑key’s multi-factor authentication and is delivered with Saudi partner Cloud Distribution. Financial terms were not disclosed.
7 November 2025
··
BIO-key (BKYI) Stock Jumps as Nordic Deal and New Biometric Tech Fuel Investor Buzz

BIO-key (BKYI) Stock Jumps as Nordic Deal and New Biometric Tech Fuel Investor Buzz

BIO-key International shares rose about 8% in two weeks, trading near $0.77 after a spike to $0.82 last week on new product news. The company signed a Nordic distribution deal with IT2Trust and launched the EcoID III fingerprint scanner. Q2 revenue jumped 49% to $1.7 million, but BIO-key remains unprofitable. The firm secured $1.13 million in new financing and reported $3.1 million in cash as of Q2.
27 October 2025
·

Stock Market Today

  • Tesla Shares Dip Amid SpaceX Rally and FSD Regulatory Concerns
    June 16, 2026, 1:42 PM EDT. Tesla shares fell 1.7% to $404.09 as investors weighed a surging SpaceX stock and regulatory scrutiny on Tesla's Full Self-Driving (FSD) system. Goldman Sachs raised Q2 vehicle delivery forecasts to 420,000 but maintained a Neutral rating and $375 price target. The stock trades at a high price-to-earnings (P/E) ratio of 371, reflecting expectations for growth from AI initiatives like robotaxis and autonomous driving. However, U.S. senators have requested a safety review of Tesla's FSD crash data by the National Highway Traffic Safety Administration (NHTSA), raising concerns about regulatory risks. Tesla's Q2 delivery report and updates on its robotaxi expansion and FSD oversight remain key near-term catalysts for the stock.

Latest articles

Tesla Stock Slips as SpaceX Rally and FSD Scrutiny Test the AI Bull Case

Tesla Stock Slips as SpaceX Rally and FSD Scrutiny Test the AI Bull Case

16 June 2026
Tesla shares dropped 1.7% to $404.09 as Goldman Sachs raised Q2 delivery estimates to 420,000 vehicles but kept a Neutral rating and $375 target, while regulatory scrutiny of Full Self-Driving intensified after two U.S. senators urged an NHTSA review, highlighting ongoing risks for investors.
Micron Drops From Highs With AI Tailwind Facing Earnings Bar

Micron Drops From Highs With AI Tailwind Facing Earnings Bar

16 June 2026
Micron Technology shares fell 3.6% to $1,048.87 after a record high, as investors took profits in the hot AI memory trade ahead of the June 24 earnings call, where results will test whether booming AI-driven memory demand can justify the stock’s 800% run and high valuation, with analysts warning that any disappointment could hit both earnings expectations and the stock’s multiple.
Eos Energy shares jump as battery factory Line 2 goes live

Eos Energy shares jump as battery factory Line 2 goes live

16 June 2026
Eos Energy Enterprises jumped nearly 11% to $7.08 after launching commercial production at its second Pennsylvania battery facility, aiming for 4 GWh annual capacity by end-2026; shares surged as much as 13% intraday, but investors face dilution risk from a July rights offering and ongoing cash burn despite a $644.6 million backlog and soaring revenue.
Go toTop